Sign inGet started

Alafi Christopher D

Insider CIK 1299430 · STXS Director, 10% owner · ITCI Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ITCI Intra-Cellular Therapies, S Sale2021-05-282021-05-2838,843$40.12 $1.56M95,000SEC↗
ITCI Intra-Cellular Therapies, S Sale2021-05-272021-05-288,482$40.01 $339.4K133,843SEC↗
ITCI Intra-Cellular Therapies, S Sale2021-05-242021-05-2526,575$40.47 $1.08M142,325SEC↗
ITCI Intra-Cellular Therapies, S Sale2021-05-212021-05-251,100$40.00 $44.0K168,900SEC↗
ITCI Intra-Cellular Therapies, A Award2021-03-312021-04-02464$33.93 $15.7K346,795SEC↗
ITCI Intra-Cellular Therapies, A Award2020-12-312021-01-05495$31.80 $15.7K346,331SEC↗
ITCI Intra-Cellular Therapies, A Award2020-09-302020-10-02613$25.66 $15.7K345,836SEC↗
ITCI Intra-Cellular Therapies, P Buy2020-09-142020-09-1449,500$29.60 $1.47M4,743,770SEC↗
ITCI Intra-Cellular Therapies, P Buy2020-09-112020-09-1121,000$28.08 $589.7K4,694,270SEC↗
ITCI Intra-Cellular Therapies, A Award2020-06-302020-07-02613$25.67 $15.7K345,223SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2020-05-272020-05-2820,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, A Award2020-03-312020-04-021,024$15.37 $15.7K344,610SEC↗
ITCI Intra-Cellular Therapies, A Award2019-12-312020-01-03422$34.31 $14.5K343,586SEC↗
ITCI Intra-Cellular Therapies, A Award2019-09-302019-10-021,941$7.47 $14.5K343,164SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-09-102019-09-11320,095$10.58 $3.39M4,667,030SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-09-102019-09-11155,116$9.59 $1.49M4,346,935SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-09-102019-09-116,240$11.00 $68.6K4,673,270SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-09-102019-09-113,549$8.98 $31.9K4,191,819SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-08-302019-09-04125,000$8.52 $1.06M4,188,270SEC↗
ITCI Intra-Cellular Therapies, A Award2019-06-282019-07-021,117$12.98 $14.5K341,223SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2019-06-252019-06-2620,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, G Gift2019-06-172019-06-19400,000— $0340,106SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-06-122019-06-1458,705$12.00 $704.5K170,000SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-06-122019-06-1416,226$10.91 $177.0K16,226SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-06-122019-06-1495,069$11.70 $1.11M111,295SEC↗
ITCI Intra-Cellular Therapies, P Buy2019-05-142019-05-15100,000$12.56 $1.26M4,053,270SEC↗
ITCI Intra-Cellular Therapies, A Award2019-03-312019-04-021,190$12.18 $14.5K750,106SEC↗
ITCI Intra-Cellular Therapies, A Award2018-12-312019-01-031,273$11.39 $14.5K748,916SEC↗
ITCI Intra-Cellular Therapies, A Award2018-09-302018-10-02668$21.70 $14.5K747,643SEC↗
ITCI Intra-Cellular Therapies, A Award2018-06-292018-07-03820$17.67 $14.5K746,975SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2018-06-182018-06-2020,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, A Award2018-03-302018-04-03688$21.05 $14.5K746,155SEC↗
ITCI Intra-Cellular Therapies, P Buy2017-12-292018-01-031,001$14.48 $14.5K745,467SEC↗
ITCI Intra-Cellular Therapies, A Award2017-12-292018-01-031,001$14.48 $14.5K745,467SEC↗
ITCI Intra-Cellular Therapies, P Buy2017-11-222019-06-1910,000$15.55 $155.5K3,963,270SEC↗
ITCI Intra-Cellular Therapies, P Buy2017-11-222017-11-2710,000$15.55 $155.5K744,466SEC↗
ITCI Intra-Cellular Therapies, P Buy2017-10-022017-10-03258,065$15.50 $4.00M3,953,270SEC↗
ITCI Intra-Cellular Therapies, A Award2017-09-292017-10-03918— $0734,466SEC↗
ITCI Intra-Cellular Therapies, A Award2017-06-302017-07-051,167— $0733,548SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2017-06-272017-06-2920,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, A Award2017-03-312017-04-04892— $0732,381SEC↗
ITCI Intra-Cellular Therapies, A Award2016-12-302017-01-03960— $0731,489SEC↗
ITCI Intra-Cellular Therapies, P Buy2016-12-072016-12-0720,826$16.14 $336.1K3,695,205SEC↗
ITCI Intra-Cellular Therapies, P Buy2016-12-062016-12-0744,174$16.33 $721.4K3,674,379SEC↗
ITCI Intra-Cellular Therapies, P Buy2016-11-142016-11-1734,000$14.50 $493.0K3,630,205SEC↗
ITCI Intra-Cellular Therapies, A Award2016-09-302016-10-04951— $0730,529SEC↗
ITCI Intra-Cellular Therapies, A Award2016-06-302016-07-05373— $0729,578SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2016-06-142016-06-1520,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, A Award2016-03-312016-04-04377— $0729,205SEC↗
ITCI Intra-Cellular Therapies, P Buy2016-02-292016-02-29100,000$29.70 $2.97M728,828SEC↗
ITCI Intra-Cellular Therapies, A Award2015-12-312016-01-05195$53.79 $10.5K628,828SEC↗
ITCI Intra-Cellular Therapies, A Award2015-09-302015-10-02262— $0628,633SEC↗
ITCI Intra-Cellular Therapies, A Award2015-06-302015-07-02328— $0628,371SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2015-06-162015-06-2220,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, A Award2015-03-312015-04-02439— $0628,043SEC↗
ITCI Intra-Cellular Therapies, P Buy2015-03-112015-03-12625,000$24.00 $15.00M627,604SEC↗
ITCI Intra-Cellular Therapies, A Award2014-12-312015-01-05594— $02,604SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-12-012014-12-031,422$14.75 $21.0K3,596,205SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-282014-11-2835,000$14.75 $516.3K3,594,783SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-192014-11-211,034$14.25 $14.7K3,559,783SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-182014-11-183,531$14.23 $50.2K3,558,749SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-142014-11-18133$15.07 $2.0K3,555,218SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-132014-11-132,200$15.12 $33.3K3,555,085SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-122014-11-135,000$15.23 $76.2K3,552,885SEC↗
ITCI Intra-Cellular Therapies, P Buy2014-11-112014-11-135,000$15.55 $77.8K3,547,885SEC↗
ITCI Intra-Cellular Therapies, A Award2014-09-302014-10-02765— $02,010SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2014-06-302014-07-0220,000— $020,000SEC↗
ITCI Intra-Cellular Therapies, A Award2014-06-302014-07-021,245— $01,245SEC↗
STXS Stereotaxis, Inc. S Sale2013-08-202013-08-2022,220$3.70 $82.2K1,266,628SEC↗
STXS Stereotaxis, Inc. S Sale2013-08-192013-08-20239,021$3.74 $893.9K1,288,848SEC↗
STXS Stereotaxis, Inc. M Exercise deriv2013-08-162013-08-20261,241$3.36 $877.8K606,249SEC↗
STXS Stereotaxis, Inc. M Exercise2013-08-162013-08-20261,241$3.36 $877.8K1,527,869SEC↗
STXS Stereotaxis, Inc. J Other deriv2013-07-312013-08-154,771— $04,771SEC↗
STXS Stereotaxis, Inc. J Other deriv2013-06-282013-08-1516,129— $016,129SEC↗
STXS Stereotaxis, Inc. P Buy deriv2012-05-102012-05-148,674,908— $08,674,908SEC↗
STXS Stereotaxis, Inc. P Buy2012-05-102012-05-148,674,908— $012,666,281SEC↗
STXS Stereotaxis, Inc. J Other deriv2012-05-072012-05-14781,018— $0781,018SEC↗
STXS Stereotaxis, Inc. J Other deriv2012-05-012012-05-03304,878— $0304,878SEC↗
STXS Stereotaxis, Inc. J Other deriv2012-03-302012-04-03378,673— $0378,673SEC↗
STXS Stereotaxis, Inc. A Award2012-01-032012-01-0517,647— $0245,933SEC↗